@Article{Brzeziński2011,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="15",
number="6",
year="2011",
title="Opioid combination. Case report",
abstract="The combination of long-acting opioids has not been sufficiently documented in the literature.  Patient J.L., aged 67, with disseminated malignant process. Complaints of pelvic and visceral pain. Treatment: sustained release morphine 60 mg/daily. There occurred a need to increase the dose of the drug up to 120 mg/daily; the patient was referred to the Pain Management  Outpatient Department. Nociceptive pain was diagnosed at the intensity  of 7.5 on the VAS scale. Ketoprofen was included in the treatment at a dose of  200 mg/daily. After three days the morphine dose was increased to 180 mg/daily. Due to the lack of adequate pain control sustained release oxycodone was started, initially at a dose of 20 mg/  daily, and after three days 40 mg/daily.  After two weeks, the dose of morphine was decreased to 140 mg/daily. Adequate pain control was obtained.",
author="Brzeziński, Krzysztof",
pages="415--417",
doi="10.5114/wo.2011.26449",
url="http://dx.doi.org/10.5114/wo.2011.26449"
}